beta-lactams has been researched along with quinazolines in 1 studies
| Studies (beta-lactams) | Trials (beta-lactams) | Recent Studies (post-2010) (beta-lactams) | Studies (quinazolines) | Trials (quinazolines) | Recent Studies (post-2010) (quinazolines) |
|---|---|---|---|---|---|
| 7,579 | 179 | 3,395 | 19,235 | 2,417 | 8,835 |
| Protein | Taxonomy | beta-lactams (IC50) | quinazolines (IC50) |
|---|---|---|---|
| Epidermal growth factor receptor | Homo sapiens (human) | 0.027 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Campbell, J; Gilmore, MS; Singh, AK; Swoboda, JG; Walker, S; Wilkinson, BJ | 1 |
1 other study(ies) available for beta-lactams and quinazolines
| Article | Year |
|---|---|
An antibiotic that inhibits a late step in wall teichoic acid biosynthesis induces the cell wall stress stimulon in Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Autolysis; Bacterial Proteins; beta-Lactams; Cell Wall; Culture Media; Methicillin-Resistant Staphylococcus aureus; Microarray Analysis; Microbial Sensitivity Tests; Microscopy, Electron; Microscopy, Electron, Transmission; Quinazolines; RNA, Bacterial; Staphylococcus aureus; Teichoic Acids; Transcription, Genetic; Triazoles; Virulence Factors | 2012 |